Search
ADU-S100
go.drugbank.com/drugs/DB14722InvestigationalADU-S100 (MIW815) is a synthetic cyclic dinucleotide (CDN) agonist (activator) of Stimulator of Interferon Genes (STING), a receptor crucial to activate the innate (endogenous) immune system. … ADU-S100 (MIW815) activates all known human and mouse STINGs, and effectively induces the expression of cytokines and chemokines, leading to a robust and durable antigen-specific T-cell mediated immune
Categories: Nucleic Acids, Nucleotides, and Nucleosides3-Allylfentanyl
go.drugbank.com/drugs/DB09169ExperimentalIllicit3-allyfentanyl is a fentanyl derivative opioid that can cause itching, nausea and serious respiratory depression. … Fentanyl and its analogs have killed thousands of people around the world as drugs of abuse.
Quisqualic acid
go.drugbank.com/drugs/DB02999ExperimentalQuisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium … The compound is obtained from the seeds and fruit of _Quisqualis chinensis_.
Categories: Amino Acids, Peptides, and ProteinsMirococept
go.drugbank.com/drugs/DB06492ExperimentalMirococept (APT070) is a complement inhibitor currently under development for treatment of rheumatoid arthritis and I/RI. … It consists of the first three short consensus domains of human complement receptor 1 (CR1), manufactured in recombinant bacteria and modified with a membrane-targeting amphiphilic peptide based on the
Synonyms: myristoylated recombinant SCR1-3 of human complement reseptor type IDistearyldimonium
go.drugbank.com/drugs/DB14143ApprovedWithdrawnSynonyms: Dioctadecyldimethylammonium ionCategories: Compounds used in a research, industrial, or household settingPHE885
go.drugbank.com/drugs/DB18123InvestigationalPHE885 is an investigational, autologous B-cell Maturation Antigen (BCMA)-directed chimeric antigen receptor (CAR)-T cell therapy.
Cepeginterferon alfa-2B
go.drugbank.com/drugs/DB12814InvestigationalCepeginterferon alfa-2B is under investigation in clinical trial NCT01889433 (An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic
Categories: Antineoplastic and Immunomodulating AgentsRDEA806
go.drugbank.com/drugs/DB05228InvestigationalRDEA806 is a new HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to resistance and a broad spectrum of activity.
Ozone
go.drugbank.com/drugs/DB12510InvestigationalOzone has been used in trials studying the treatment of Mild Asthma and Primary Apical Periodontite.
Categories: Compounds used in a research, industrial, or household settingPipequaline
go.drugbank.com/drugs/DB13991ExperimentalPipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed. … Due to these differences, this drug is classified as a nonbenzodiazepine anxiolytic.